Waldenstrom Macroglobulinemia: A Slow Blood Cancer and How It Is Managed

Last updated September 4, 2026.

Waldenstrom macroglobulinemia, often shortened to WM, is a slow-growing cancer of a type of white blood cell. The affected cells pour out a large protein called IgM, and it is that protein, plus the cells crowding the bone marrow, that causes most of the trouble. It is uncommon, it usually appears later in life, and it behaves more like a chronic condition than an emergency: many people live with it for years, and a good number need no treatment at all for a long time.

What the protein does

IgM is a big molecule, and in large amounts it thickens the blood. When the blood gets thick enough, a state called hyperviscosity, people get headaches, blurred vision, nosebleeds, dizziness, and confusion. The protein can also damage nerves in the hands and feet, causing numbness and tingling, and it can interfere with normal clotting. Meanwhile the cells making the protein fill the bone marrow and crowd out normal blood production, which brings anemia, fatigue, and lowered resistance to infection.

With WM, no treatment is a real plan: monitoring catches the moment treatment will help, and starting earlier only adds side effects. Know the thick-blood symptoms and keep every appointment.

Start a free AI doctor consult →

How it is found

Many people are diagnosed from a routine blood test that shows an unexpected protein spike or an unexplained anemia, before any symptoms at all. The diagnosis is confirmed with blood protein measurements, a bone marrow sample, and genetic tests on the cells, which also help guide treatment choices later.

Watch and wait, then treat when it matters

The most surprising part of WM for most people is the first prescription: nothing. If there are no symptoms and the blood counts are stable, the standard of care is regular monitoring, because treatment given early does not extend life and only brings side effects. Treatment starts when the disease causes problems: significant anemia, symptoms from the thick blood, nerve damage, or an enlarging spleen or lymph nodes. When treatment is needed, the main options are combinations built around rituximab, and a class of pills called BTK inhibitors that block the signal the cancer cells depend on. If the blood thickness becomes an emergency, plasma exchange clears the protein within hours. This is a condition people live with, often for many years, and new medicines have improved the picture considerably over the last decade.

No treatment is a treatment plan. Monitoring visits with stable results are the desired outcome, not a doctor doing nothing. Early treatment does not help and carries real costs.
Know the thick-blood symptoms. New blurred vision, nosebleeds, headaches, dizziness, or confusion mean an urgent call to the blood team, because hyperviscosity is treatable quickly once recognized.
Report infections promptly. WM and its treatments lower immune defenses. Fevers and infections deserve earlier attention than you might give them otherwise.

If you are weighing the risks and benefits of any medicine mentioned here, our overview of how medicines are tested and monitored for safety explains what those conversations are built on.

What a Pymander AI doctor consult looks like

I am 66 and a routine blood test just found Waldenstrom macroglobulinemia. I have no symptoms. The hematologist says we are not treating it, just watching. How can I have cancer and do nothing about it?

It sounds backwards, and it is one of the best-supported decisions in blood medicine. WM grows slowly, and studies over decades have shown that treating it before symptoms does not help people live longer; it only exposes them to side effects earlier. The monitoring is active, not passive: regular blood tests track the protein level and your counts, and the team has clear triggers for starting treatment, which are symptoms, significant anemia, or signs the thick blood is straining you. Many people monitored this way go years without needing anything. The word cancer is doing a lot of work in your head right now, and it is worth updating: WM behaves more like a chronic condition you manage than the emergencies the word usually summons. Your jobs while watching are simple: keep every appointment, learn the thick-blood symptoms (blurred vision, nosebleeds, headaches, dizziness), and call promptly about fevers or infections. And when treatment time comes, the options are far better than they were even ten years ago.

Thanks for giving me all this information. A cancer found by accident, with the plan being to do nothing, takes some mental adjustment, and your question is the one everyone asks first. The watch-and-wait approach is the correct standard of care, backed by decades of evidence, and the fact that you qualify for it is itself good news. Keep the appointments, know the symptoms that change the plan, and let the team carry the watching with you. Bring your list of questions to the hematologist, and ask what specifically would trigger treatment in your case, because a concrete answer to that makes the waiting much easier to live inside.

Care note

New-diagnosis consult, 66M asymptomatic WM on watch and wait. The central task is legitimizing non-treatment: decades of evidence that early treatment does not extend life. Reframing cancer as a chronic condition is the emotional work; the symptom list is the practical work. Asking for a concrete trigger turns vague monitoring into a plan.

Careful not to promise years without treatment as certain (many, not all). Hyperviscosity symptoms kept as the urgent-call list because that is the one true emergency in this condition. Sources: Cleveland 17951, Mayo drc-20359986. No chains, banned adverbs absent.

View care note →

Illustrative example, not a real member's messages.

Common questions

Why am I not being treated if I have cancer?

Because treatment before symptoms does not help people with WM live longer, and it brings side effects sooner. Decades of evidence support monitoring until the disease causes problems. Many people go years before needing treatment, and some never do.

What symptoms mean the disease is becoming active?

The important ones are blurred vision, nosebleeds, headaches, dizziness, or confusion (signs the blood is getting thick), increasing fatigue or breathlessness (anemia), numbness or tingling in the hands and feet, and enlarged lymph nodes or spleen. Any of these means a prompt call to the blood team.

What is hyperviscosity?

It is the blood becoming too thick because of the IgM protein. It can cause headaches, blurred vision, nosebleeds, and confusion. When severe it is an emergency, but it responds quickly to plasma exchange, a procedure that filters the protein out of the blood.

What treatment will I get when the time comes?

The main options are combinations built around rituximab, and a class of daily pills called BTK inhibitors that block a signal the WM cells depend on. The choice depends on your symptoms, counts, and genetic features of the cells, and your team will walk through the options when treatment is actually needed.

Will this shorten my life?

WM is a slow-moving condition and many people live with it for many years, often dying with it rather than from it. Outcomes have improved considerably with the newer medicines. Your own outlook depends on factors your hematologist can discuss once the full test results are in.

Is WM inherited?

Almost always not. A small increase in risk has been seen in close relatives, but routine screening of family members is not recommended. It is not something you pass to your children the way an inherited condition works.

Sources

Pymander is not a replacement for a physician and does not provide medical advice, diagnosis, or treatment.